II
WST icon

Ibex Investors’s West Pharmaceutical WST Stock Holding History

Ibex Investors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,676
Closed -$207K – 257
2018
Q3 		$207K Buy
+1,676
New +$188K 0.11% 132
2018
Q1 		– Sell
-2,634
Closed -$263K – 277
2017
Q4 		$263K Buy
+2,634
New +$258K 0.15% 121

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Ibex Investors's WST Position: Q4 2018 in Review

Ibex Investors sold out of West Pharmaceutical (WST) in Q4 2018, closing a stake of 1,676 shares — an estimated $207K sold.

Ibex Investors first reported a position in WST in Q4 2017 and held it in 2 quarters. The position peaked at $263K in Q4 2017. 355 funds tracked by Wall St. Rank hold WST as of Q4 2018.

  • Ibex Investors reported no remaining West Pharmaceutical position as of Q4 2018 after selling out during the quarter.
  • Ibex Investors sold 1,676 West Pharmaceutical shares in Q4 2018, an estimated $207K.
  • Ibex Investors first reported a position in West Pharmaceutical in Q4 2017 and held it in 2 quarters.
  • Ibex Investors's West Pharmaceutical position peaked at $263K in Q4 2017.
  • 355 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2018.

Based on Ibex Investors's 13F filing for Q4 2018, filed 13 Feb 2019.